Sensitivity analysis of different HER2 clone numbers for detecting HER2 low and ultra-low expression in invasive breast cancer

被引：0
|
作者：
Liu, Y. [1 ]
Shang, J. [1 ]
He, J. [1 ]
Ding, Y. [1 ]
Li, J. [1 ]
机构：
[1] Hebei Med Univ, Hosp 4, Shijiazhuang, Hebei, Peoples R China
来源：
VIRCHOWS ARCHIV | 2024年 / 485卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
E-PS-02-05
引用
收藏
页码：S197 / S198
页数：2
相关论文
共 50 条
  • [1] Is HER2 ultra-low breast cancer different from HER2 null or HER2 low breast cancer? A study of 1363 patients
    Chen, Zhaoxu
    Jia, Huiqing
    Zhang, Huina
    Chen, Lifang
    Zhao, Peng
    Zhao, Jing
    Fu, Guangming
    Xing, Xiaoming
    Li, Yujun
    Wang, Chengqin
    BREAST CANCER RESEARCH AND TREATMENT, 2023, 202 (02) : 313 - 323
  • [2] Is HER2 ultra-low breast cancer different from HER2 null or HER2 low breast cancer? A study of 1363 patients
    Zhaoxu Chen
    Huiqing Jia
    Huina Zhang
    Lifang Chen
    Peng Zhao
    Jing Zhao
    Guangming Fu
    Xiaoming Xing
    Yujun Li
    Chengqin Wang
    Breast Cancer Research and Treatment, 2023, 202 : 313 - 323
  • [3] HER2 Low, Ultra-low, and Novel Complementary Biomarkers: Expanding the Spectrum of HER2 Positivity in Breast Cancer
    Venetis, Konstantinos
    Crimini, Edoardo
    Sajjadi, Elham
    Corti, Chiara
    Guerini-Rocco, Elena
    Viale, Giuseppe
    Curigliano, Giuseppe
    Criscitiello, Carmen
    Fusco, Nicola
    FRONTIERS IN MOLECULAR BIOSCIENCES, 2022, 9
  • [4] Understanding the spectrum of HER2 status in breast cancer: From HER2-positive to ultra-low HER2
    Ahuja, Sana
    Khan, Adil Aziz
    Zaheer, Sufian
    PATHOLOGY RESEARCH AND PRACTICE, 2024, 262
  • [5] Novel Quantitative HER2 Assay for Determining Dynamic HER2 Expression in the HER2 IHC 0 "Ultra-Low" Setting: Implications for Precision Therapy in HER2-Breast Cancer
    Petricoin, Emanuel F.
    Corgiat, Brian A.
    O'Shaughnessy, Joyce
    LoRusso, Patricia
    Weinberg, Kris
    Davis, Justin
    Gawryletz, Chelsea
    CANCER RESEARCH, 2023, 83 (05)
  • [6] Evaluating Low HER2 Status in Breast Cancer Cases with Absent and Low HER2 Protein Expression
    Ardor, Gokce
    Komforti, Miglena
    Hanna, Helena
    Nassar, Aziza
    LABORATORY INVESTIGATION, 2023, 103 (03) : S94 - S95
  • [7] Examination of low Her2 expression in breast cancer
    Fernandez, Aileen I.
    Liu, Matthew
    Bellizzi, Andrew
    Brock, Jane
    Fadare, Oluwole
    Hanley, Krisztina
    Harigopal, Malini
    Jorns, Julie M.
    Kuba, M. Gabriela
    Ly, Amy
    Podoll, Mirna
    Rabe, Kimmie
    Sanders, Mary Ann
    Singh, Kamaljeet
    Snir, Olivia L.
    Soong, Rinda
    Wei, Shi
    Wen, Hannah
    Wong, Serena
    Yoon, Esther
    Pusztai, Lajos
    Reisenbichler, Emily
    Rimm, David L.
    CANCER RESEARCH, 2022, 82 (04)
  • [8] Redefining therapeutic landscapes: clinicopathological insights into low and ultra-low HER2 expression in male breast cancer
    Jiuyan Shang
    Jiaxian Miao
    Shuyao Niu
    Xuemei Sun
    Yueping Liu
    Diagnostic Pathology, 20 (1)
  • [9] How can the varied tumour FFPE blocks with HER2 ultra-low influenced on the accurate diagnosis of HER2 in breast cancer
    Liu, Y.
    Li, J.
    Liu, H.
    Ding, Y.
    Wu, S.
    Shang, J.
    VIRCHOWS ARCHIV, 2024, 485 : S1 - S1
  • [10] HER2 low and ER low breast cancer
    Schnitt, Stuart
    JOURNAL OF PATHOLOGY, 2023, 261 (SUPPL1): : S7 - S7
12345